Clinical Trials Directory

Trials / Conditions / First-line Therapy

First-line Therapy

8 registered clinical trials studyying First-line Therapy — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEfficacy and Safety of QL1706 Combined With Nab-paclitaxel and Cisplatin as 1st Line Therapy for Advanced or M
NCT07533305
The First Affiliated Hospital of Henan University of Science and TechnologyPhase 2
RecruitingZanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroeso
NCT07176312
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestPhase 2
Not Yet RecruitingTrastuzumab Rezetecan Combined With Pertuzumab and Iparomlimab and Tuvonralimab for Biliary Tract Cancer
NCT07129018
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 2
RecruitingLow Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastati
NCT07050043
Dr Arvindran A/L AlagaPhase 3
Not Yet RecruitingFruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
NCT06888037
Ruijin HospitalPhase 2
Active Not RecruitingA Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients
NCT06928376
Chinese PLA General HospitalPhase 2
RecruitingFruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanc
NCT07334431
Henan Cancer HospitalPhase 1 / Phase 2
CompletedCAPOX + Bevacizumab + Tislelizumab Treating PD-L1 CPS < 5 Locally Advanced or Metastatic GEA
NCT05299476
Chinese PLA General HospitalPhase 2